logo-loader

AIM Breakfast: Petards Group, Marlowe PLC, RedT Energy, Tern, Greatland Gold, ImmuPharma, Galantas Gold, Scancell Holdings, Immedia Group, Provexis

no_picture_pai.jpg

What’s cooking in the IPO kitchen?
Jackpotjoy—Press reports Canadian online Bingo firm currently known as Intertain (TSX) to vote on an October IPO in London
Misys— The press reports that the Banking Technology provider owned by Vista Equity Partners is seeking a £5.5bn float in London
Bacanora Lithium— To list on AIM around 28 Sep as holding company for TSX listed Bacanora Minerals at £100m market cap
Aura Energy—ASX listed uranium developer (ASX:AEE) expected to join AIM 8 September raising up to £2.85m at £8.1m mkt cap

Breakfast buffet

Petards Group (LON:PEG) 17.75p £6.2m
Interims from the developer of advanced security and surveillance systems. Fifth consecutive half of profit growth. Total revenues increased 22% to £7.4m, with total  EBITDA up 29% to £786k and diluted EPS up 25% to 0.95p.
The £12m period end order book has been further boosted by the receipt of over £4m of orders primarily for Petards eyeTrain systems for commuter trains. 10.9x diluted 2016E earnings falling to 9.6x for 2017.

Marlowe PLC (LON:MRL) 167.5p £35.8m
Marlowe, formed to acquire and develop target businesses operating in the outsourced business services sector in the UK  has released an AGM Statement. Trading in line. Integration going to plan. Continues to seek opportunities to add scale to platform for growth in fire protection, security systems and water treatment services and looks forward to delivering a strong performance in  first full year of trading as a Group.  FYMar17E revs of £32.8m. EPS 7.1p. PE 23.6x

RedT Energy (LON:RED) 8.12p £38m
The energy storage technology company, is working with Newcastle University in a Knowledge Transfer Partnership to research and develop the first ever hybrid energy storage system. The project has received £149,062 funding from Innovate UK partners; Engineering & Physical Sciences Research Council and the Scottish Funding Council.  The 3 year project aims to combine the redT flow energy storage machine with short duration power intensive storage solutions like lithium batteries.

Tern (LON:TERN) 9.6p £7.6m
The company specialising in the cloud and Internet of Things sectors announced that its subsidiary, Device Authority, a specialist in policy & device driven security for IoT & a Gartner Cool Vendor, has formed a strategic partnership with DigiCert, a provider of  identity & authentication solutions, providing enhanced device provisioning & credential management for the IoT. The partnership helps expand & enable the range of IoT devices that can be secured with encryption, authentication & credential management.

Greatland Gold (LON:GGP) 0.25p £4m
The precious and base metals exploration and development business announced that the Programme of Work application for the Ernest Giles gold project has been approved and field operations have now commenced.  The project covers a significant portion of a large greenstone belt that has been subject to little historical exploration. The large greenstone belts in Western Australia host multiple million ounce gold deposits and the intention is to determine whether similar deposits may be hosted within this remote and largely unexplored greenstone belt.

ImmuPharma (LON:IMM) 34.5p £42m
The specialist drug discovery and development company, has updated on the progress of its Phase III clinical trial of Lupuzor™, its lead programme for the potential breakthrough compound for Lupus, the life threatening auto-immune disease. 30 further patients to be enrolled at a new site in Mauritius where Lupus prevalence is high. Lupus Alert', the country's pre-eminent Lupus foundation has been following the progress of Lupuzor™ since the commencement of its pivotal Phase III trial.

Galantas Gold (LON:GAL) 8.75p £12.06m
The gold developer in Northern Ireland has identified amongst its recent drilling results the presence of a gold vein stringer in the western part of the Kearney vein system. Core H159 (reported 24th August 2016) intersected 1 metre of mineralisation grading 5.7 g/t gold and 6.2 g/t silver. The vein stringer was not previously worked within the open pit because it lay close to the edge of the permitted open pit mining envelope.  This may allow earlier mining of ore than previously anticipated.

Scancell Holdings (LON:SCLP) 18.25p £47.7m
The developer of novel immunotherapies for the treatment of cancer, announced that it will be presenting at the 23rd Annual NewsMakers in the Biotech Industry Conference. The conference is being held on 9 September 2016 at the Millennium Broadway Hotel & Conference Center in New York City, USA.

Immedia Group (LON:IME) 26p £3.78m
The supplier of digital audio content solutions for leading brands and global businesses, announces has acquired the business and certain assets comprising AVC Media for £200k from AVC’s administrators. AVC Media's last audited accounts for the year ended 31 March 2015, showed revenue of £5.9m, profit before tax of £0.09m and net assets of £0.08m. Immedia sees synergy and cost cutting opportunities.

Provexis (LON:PXS) 0.49p £8.27m
The business that develops and licenses the proprietary, scientifically-proven Fruitflow® heart-health functional food ingredient, announces its audited preliminary results for the year ended 31 March 2016.  Revenue from profit sharing Alliance for the year £92k, a 140% year on year increase. Total loss of £410k. Enhanced financial terms with DSM. Clinical trial on blood pressure to complete in Q4

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Qrons seeking to find a cure for traumatic brain injuries...

Qrons Inc (OTCQB: QRON) CEO Jonah Meer tells Proactive the New York-based biotechnology company is developing two products, one of which involves a 3D-printable scaffold, aimed at helping to treat traumatic brain injuries. Meer says that traumatic brain injuries are the number one cause of...

13 hours, 34 minutes ago

5 min read